View in EDS

Carbapenem or new β-lactam-β-lactamase inhibitors? An Italian survey supported by SITA, SIMIT and SIAARTI to identify the factors affecting empiric antimicrobial therapy choice in real-life clinical practice.

Saved in:
Bibliographic Details
Title: Carbapenem or new β-lactam-β-lactamase inhibitors? An Italian survey supported by SITA, SIMIT and SIAARTI to identify the factors affecting empiric antimicrobial therapy choice in real-life clinical practice.
Authors: Colaneri, Marta1,2 (AUTHOR) marta.colaneri@gmail.com, Genovese, Camilla1,3 (AUTHOR), Lombardi, Andrea3,4 (AUTHOR), Holmes, Darcy4 (AUTHOR), Bandera, Alessandra3,4 (AUTHOR), Gori, Andrea1,2 (AUTHOR)
Source: European Journal of Clinical Microbiology & Infectious Diseases. May2024, Vol. 43 Issue 5, p1017-1023. 7p.
Database: Environment Complete
Description
ISSN:09349723
DOI:10.1007/s10096-024-04798-8